The primary endpoints of TROPION-Lung02 are dose-limiting toxicities and treatment-emergent adverse events. Secondary endpoints include ORR, DoR, PFS as assessed by investigator, overall survival, ...

AI will deliver transformative therapies at an exponential scale, addressing the complexities of biology that traditional ...

I n her State of the City address in March, Mayor Michelle Wu spoke about her then-2-month-old daughter. The world she ...

A monument to Josef Stalin has been unveiled in one of Moscow’s busiest subway stations, the latest attempt by Russian ...

A disconnect between upstream and downstream work continues to hold back progress in biomanufacturing, claims the CEO of ...

At Clone, a pioneering robotics company headquartered in Poland and California, Wiktoria Kruk, Vice President of Biomechanics ...

Here in the U.S., many startups are facing hard questions about how they’ve grown: bloated valuations, misaligned incentives, shallow product pipelines. The contrast with Korea’s quiet biotech ascent ...

Mettler-Toledo’s capital efficiency, strong moat, and robust free cash flow make it a standout investment. Click here to find ...

RBL LLC, a pioneering biotech venture creation studio dedicated to rapidly building companies based on breakthrough medical technologies from Rice University, today announced the launch of Sentinel ...

Equity Insider News Commentary – With early onset cancer rates on the rise and funding being cut to NIH, the future for cancer patients is increasingly being shaped not by public institutions, but by ...

AN2 Therapeutics, Inc. , a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced that the company ...